- Quality & Risk
- QRM Process
IFPAC 2009: FDAs Moore on Where QbDs Been, and Where Its Going
FDA CDERs Christine Moore, PhD, acting deputy director of the Office of New Drug Quality Assessment, explains how her office is leading the Agency in moving from conceptual QbD to actual implementation. Gary Ritchie interviews (with a cameo from Emil Ciurcak).